Year 2017 / Volume 24 / Number 5

Abstract PDF

Original

Pain management in cancer patients receiving radiotherapy: GORVAMUR study, a prospective, observational, epidemiological study

Rev Soc Esp Dolor 2017; 24(5): 241-255 / DOI: 10.20986/resed.2017.3570/2017

J. L. Menguall, J. L. Monroy2, A. Fondevilla3, R. Cañón4, G. Vázquez5, M. Santos6, P. Soler7, F. J. Martínez8, A. Moreno9, E. Jordá10, R. García11 y A. Gónzalez12 1Servicio de Oncología Radioterápica FIVO. Fundación Instituto Valenciano de Oncología. Valencia. 2Servicio de Oncología Radioterápica. Hospital de La Ribera. Alzira, Valencia.


ABSTRACT

Objectives: To assess breakthrough pain management in patients at radiation oncology and its impact on pain control in these patients, as well as the tolerability of the analgesic
treatments used and the satisfaction and impact on the quality of life of patients.

Material and methods: An epidemiological, observational, prospective, multicentre study carried out in patients diagnosed with cancer and with cancer pain treated with a 3rd step analgesic therapy who had begun radiotherapy treatment (RT) susceptible to modification by an oncologist, for pain control. Patients were recruited from 15 Radiation Oncology Services centres from the regions of Valencia and Murcia between May 2013
and December 2014. Patient data collected included: demographic data, basal cancer process characterization and baseline pain, and information on basal analgesic treatment and RT employed.
Pain level was recorded at 1 and 3 months by assessing: the change in the dimension of Brief Pain Inventory (BPI) pain and the amount of pain caused by episodes of breakthrough pain, the level of satisfaction, the quality of life (EQ-5D), and the
tolerability to analgesic treatment.

Results: Patients included in the analysis (n = 49) were mainly males (72.3 %) and the mean age (± Standard Deviation) was 63.7 ± 11.5 years. In 26.5 % of patients the tumours
were located in lungs and 28.6 % in head and neck. All but one of the patients reported pain during the baseline visit (20.8 % due to the primary tumour, 54.2 % to metastases, and 22.9 % to RT treatment). The median (Q1-Q3) number of breakthrough crises/day was 3.0 (2-4.5). Overall, 60.4 % were receiving treatment for breakthrough pain and Fentanyl was the most commonly used drug (70.4 %). Pain management strategies were: reinforcement/modification of long-term analgesics (30.4 %), reinforcement/modification of short-term analgesics (21.7 %), reinforcement/modification of long-term and short-term
analgesics (21.7 %), and decrease/suppression of any fast- or long-term analgesics (26.1 %). Independently from the strategy, a decrease in the maximum pain and the total amount of pain were observed over time, and an improvement during the follow-up visits was observed in the quality of life, health gain, and overall treatment satisfaction. Only two adverse reactions were reported.

Conclusions: Breakthrough pain in cancer patients, who underwent radiotherapy treatment, is a symptom of high prevalence.
There is no predominant analgesic strategy in the management of these patients, but Fentanyl is the drug most frequently used. Patients are very satisfied with the pharmacologic treatment and the reduction in the breakthrough pain obtained has a favourable effect on the global health status and quality of
life of patients.

Key words: Breakthrough cancer pain, radiotherapy, fentanyl.


Nuevo comentario

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comentarios

No comments in this article

Artículos relacionados

Instrucciones para citar

J. L. Menguall, J. L. Monroy2, A. Fondevilla3, R. Cañón4, G. Vázquez5, M. Santos6, P. Soler7, F. J. Martínez8, A. Moreno9, E. Jordá10, R. García11 y A. Gónzalez12 1Servicio de Oncología Radioterápica FIVO. Fundación Instituto Valenciano de Oncología. Valencia. 2Servicio de Oncología Radioterápica. Hospital de La Ribera. Alzira, Valencia.. Pain management in cancer patients receiving radiotherapy: GORVAMUR study, a prospective, observational, epidemiological study. Rev Soc Esp Dolor 2017; 24(5): 241-255 / DOI: 1020986/resed20173570/2017


Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 50390 veces.
Este artículo ha sido descargado 22 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Compartir

Este artículo aun no tiene valoraciones.
Reader rating:
Rate this article:
Send by e-mail
© 2024 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexada en:
Política de Privacidad